ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is held by 184 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 10,860,977 | 0 | 0.00% | $87,213,645.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 10,860,977 | 0 | 0.00% | $126,530,382.00 |
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 8,288,510 | 0 | 0.00% | $96,561,142.00 |
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 8,288,510 | 0 | 0.00% | $66,556,735.00 |
| Rubric Capital Management LP | 31 Mar, 2026 | 8,000,000 | 1,800,000 | 29.03% | $64,240,000.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Mar, 2026 | 7,503,812 | 0 | 0.00% | $87,419,410.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Mar, 2026 | 7,503,812 | 0 | 0.00% | $60,255,610.00 |
| Rubric Capital Management LP | 31 Mar, 2026 | 6,200,000 | 1,700,000 | 37.78% | $72,230,000.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 5,982,919 | 2,814,513 | 88.83% | $48,042,840.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,085,317 | 253,990 | 5.26% | $59,243,944.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,012,254 | -73,063 | -1.44% | $40,248,399.00 |
| Aberdeen Group plc | 31 Mar, 2026 | 4,113,617 | 557,568 | 15.68% | $33,032,345.00 |
| SR ONE CAPITAL MANAGEMENT, LP | 31 Mar, 2026 | 4,012,903 | 0 | 0.00% | $46,750,320.00 |
| SR ONE CAPITAL MANAGEMENT, LP | 31 Mar, 2026 | 4,012,903 | 0 | 0.00% | $32,223,611.00 |
| Tyro Capital Management LLC | 31 Mar, 2026 | 3,989,704 | 3,989,704 | 0.00% | $46,480,050.00 |
| State Street Corp | 31 Mar, 2026 | 3,644,966 | 421,385 | 13.07% | $29,269,077.00 |
| Aberdeen Group plc | 31 Mar, 2026 | 3,556,049 | 459,027 | 14.82% | $41,427,971.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 3,509,174 | 8,871 | 0.25% | $40,881,877.00 |
| Franklin Resources Inc | 31 Mar, 2026 | 3,278,549 | 735,452 | 28.92% | $26,326,745.00 |
| State Street Corp | 31 Mar, 2026 | 3,223,581 | 328,325 | 11.34% | $37,554,719.00 |